X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AMAR REMEDIES with THE PROCTER & GAMBLE CO. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs P&G (US) - Comparison Results

P&G (US)
   Change

Procter & Gamble Company (P&G) is an American multinational consumer goods company headquartered in the United States. The company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   P&G
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
P&G
Jun-14
AMAR REMEDIES/
P&G
5-Yr Chart
Click to enlarge
High Rs1646,119-   
Low Rs865,248-   
Sales per share (Unadj.) Rs261.62,155.1-  
Earnings per share (Unadj.) Rs17.4302.1-  
Cash flow per share (Unadj.) Rs22.3383.6-  
Dividends per share (Unadj.) Rs0174.69-  
Dividend yield (eoy) %03.1 0.0%  
Book value per share (Unadj.) Rs100.71,795.8-  
Shares outstanding (eoy) m26.162,748.03-   
Bonus/Rights/Conversions -BB, ESOP-  
Price / Sales ratio x0.52.6 18.1%   
Avg P/E ratio x7.218.8 38.2%  
P/CF ratio (eoy) x5.614.8 37.9%  
Price / Book Value ratio x1.23.2 39.2%  
Dividend payout %057.8 0.0%   
Avg Mkt Cap Rs m3,27015,618,922 0.0%   
No. of employees `000NA118.0 0.0%   
Total wages/salary Rs m1630-   
Avg. sales/employee Rs ThNM50,189.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM7,035.1-  
INCOME DATA
Net Sales Rs m6,8445,922,321 0.1%  
Other income Rs m2121,818 0.1%   
Total revenues Rs m6,8655,944,138 0.1%   
Gross profit Rs m1,1311,319,549 0.1%  
Depreciation Rs m128223,953 0.1%   
Interest Rs m39850,552 0.8%   
Profit before tax Rs m6261,066,862 0.1%   
Minority Interest Rs m0-10,125 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121226,591 0.1%   
Profit after tax Rs m455830,146 0.1%  
Gross profit margin %16.522.3 74.2%  
Effective tax rate %19.321.2 91.0%   
Net profit margin %6.614.0 47.4%  
BALANCE SHEET DATA
Current assets Rs m4,9042,254,292 0.2%   
Current liabilities Rs m3,5812,404,664 0.1%   
Net working cap to sales %19.3-2.5 -761.3%  
Current ratio x1.40.9 146.1%  
Inventory Days Days12430 418.4%  
Debtors Days Days10028 356.9%  
Net fixed assets Rs m1,6891,590,275 0.1%   
Share capital Rs m262365,056 0.1%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,6354,934,958 0.1%   
Long term debt Rs m5071,412,524 0.0%   
Total assets Rs m6,86210,208,306 0.1%  
Interest coverage x2.622.1 11.6%   
Debt to equity ratio x0.20.3 67.2%  
Sales to assets ratio x1.00.6 171.9%   
Return on assets %12.48.6 144.1%  
Return on equity %17.316.8 102.7%  
Return on capital %31.017.4 177.7%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-313995,205 -0.0%  
From Investments Rs m-489-292,829 0.2%  
From Financial Activity Rs m769-518,993 -0.1%  
Net Cashflow Rs m-33183,384 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for P&G (US) is United States Dollars. All data has been converted at 71.3 Rs / USD

Compare AMAR REMEDIES With: UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  

Compare AMAR REMEDIES With: K.S.OILS LTD  BAJAJ CORP  P&G HYGIENE  LINC PEN & PLASTICS LTD  RELAXO FOOTWEARS  



Today's Market

Sensex Ends 274 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued to witness selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS